Saturday, 16 November 2013
Contact Us
Search
Home
About us
Corporate Overview
History
Management Team
Advisory Boards
Partnering & Licensing
Contact
Contact Us
Impressum
News
Current News
Current Publications
News Archive
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1999
1998
Publications Archive
RESprotect Publications
Other relevant Publications
Newsletter
Chemogenomics
Product Portfolio
Pipeline Summary
RP101
RP101 Inhibition
Hsp27
Key Effects
Interaction
Hsp27 Suppression
Pancreatic Cancer
The Role of Hsp27
Clinical Effects of RP101
Summary of Clinical Trials
Competitive Advantage
2nd Generation
Navigation
Current News
Current Publications
News Archive
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1999
1998
Publications Archive
RESprotect Publications
Other relevant Publications
Newsletter
Home
News
News Archive
2006
News 2006
Filter
Order
Date asc
Date desc
Title asc
Title desc
Hits asc
Hits desc
Author asc
Author desc
Ordering
Display #
5
10
15
20
25
30
50
Date
Title
Author
Hits
Thu, 12 Oct 2006
RP101 improves the efficacy of chemotherapy
LeadDiscovery Ltd.
4116
Mon, 21 Aug 2006
Clinical Status 2006
BioCentury
4053
Sun, 21 May 2006
8th Guide to German Biotech Companies 2006
Biocom AG
4123
Tue, 02 May 2006
Combating Chemoresistance
Samedan Ltd.
4916
Mon, 20 Mar 2006
Living science
Capital of Saxony Dresden
3759
Wed, 15 Mar 2006
Netzwerk BioMeT vor Ort - Auftakt 2006
BioMeT e.V. Dresden
3702
Fri, 10 Feb 2006
A warts-and-all view of Avantogen's pancreatic
Southern Cross Equities Ltd.
4345
Thu, 02 Feb 2006
Avantogen and Innovate Merge Key Oncology Program, RP101
Avantogen Ltd. / Innovate Oncology Inc.
4239
<< Start
< Prev
1
Next >
End >>
Results 1 - 8 of 8
News 2011
( 4 items )
News 2010
( 2 items )
News 2009
( 4 items )
News 2008
( 8 items )
News 2007
( 3 items )
News 2005
( 8 items )
News 2004
( 7 items )
News 2003
( 1 items )
News 2002
( 2 items )
News 2001
( 2 items )
News 2000
( 4 items )
News 1999
( 5 items )
News 1998
( 1 items )
[ Back ]